Wednesday, January 08, 2025 4:22:48 PM
Now, that doesn't mean that their INTENTIONS are pure. They may know full well that scripts are being filled for CVD indications. But they can just play stupid.
This goes back to the whole idea that the industry is completely messed up.
Recent AMRN News
- New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients • GlobeNewswire Inc. • 11/09/2025 09:15:00 PM
- Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025 • GlobeNewswire Inc. • 11/03/2025 01:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2025 08:30:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/29/2025 11:05:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2025 11:05:27 AM
- Amarin Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 10/29/2025 11:00:00 AM
- Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit • GlobeNewswire Inc. • 10/27/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2025 09:00:31 PM
- Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025 • GlobeNewswire Inc. • 10/15/2025 12:00:00 PM
- Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress • GlobeNewswire Inc. • 10/14/2025 12:00:00 PM
- Amarin Shares Rise on ESC Congress Data Highlighting VASCEPA Mechanism • IH Market News • 09/02/2025 02:14:24 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025 • GlobeNewswire Inc. • 08/31/2025 12:30:00 PM
- New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups • GlobeNewswire Inc. • 08/30/2025 12:30:00 PM
- New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025 • GlobeNewswire Inc. • 08/25/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/04/2025 09:00:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/30/2025 11:05:53 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2025 11:05:29 AM
- Amarin Reports Second Quarter 2025 Financial Results • GlobeNewswire Inc. • 07/30/2025 11:00:00 AM
- Form F-6 - Registration of American Depository Receipt shares, not immediately effective • Edgar (US Regulatory) • 07/23/2025 01:02:53 PM
- Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025 • GlobeNewswire Inc. • 07/23/2025 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/01/2025 01:30:04 AM
- Amarin Stock Surges 11% After $25 Million Licensing Deal with Recordati • IH Market News • 06/24/2025 02:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/24/2025 11:05:28 AM
- Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe • GlobeNewswire Inc. • 06/24/2025 11:00:00 AM
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations • SNGX • Dec 4, 2025 10:18 AM
I-ON Digital Corp. Deploys $200 Million in Assets Under Management (AUM), Backed By In Situ Gold Reserves, As I-ON's Treasury Solidifies Diversified Yield Strategies From Digital Asset Deployment • IONI • Dec 4, 2025 8:30 AM
Metavesco Fast-Tracks OTC Prediction Market Platform • MVCO • Dec 3, 2025 9:12 AM
Scientists Pointing to Hidden Power Source That Could Reshape Future of AI • MAXXF • Dec 3, 2025 9:00 AM
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now • PFE • Dec 2, 2025 9:00 AM
Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order • BLO • Dec 2, 2025 8:50 AM
